These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6816008)

  • 1. Three types of growth inhibition among strains of Neisseria meningitidis isolated from patients in Norway.
    Jyssum K; Allunans J
    Acta Pathol Microbiol Immunol Scand B; 1982 Oct; 90(5):335-40. PubMed ID: 6816008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory spectrum of bacteriocin-like agents from Neisseria meningitidis.
    Jyssum K; Allunans J
    Acta Pathol Microbiol Immunol Scand B; 1984 Jun; 92(3):159-63. PubMed ID: 6435390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of bacteriocin-like activity in batch cultures of Neisseria meningitidis and consequences for genetic recombination.
    Jyssum K; Allunans J
    Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):107-11. PubMed ID: 6408888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition among strains of Neisseria gonorrhoeae due to production of inhibitory free fatty acids and lysophosphatidylethanolamine: absence of bacteriocins.
    Walstad DL; Reitz RC; Sparling PF
    Infect Immun; 1974 Sep; 10(3):481-8. PubMed ID: 4214772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriocins in Neisseria meningitidis. Screening of systemic patient strains and pharyngeal isolates from healthy carriers.
    Allunans J; Bøvre K
    APMIS; 1996 Mar; 104(3):206-12. PubMed ID: 8611195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of bacteriocin-like agents from Neisseria meningitidis on strains isolated from patients and carriers.
    Jyssum K; Allunans J
    Acta Pathol Microbiol Immunol Scand B; 1984 Jun; 92(3):165-70. PubMed ID: 6435391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reevaluation of bacteriocinogeny in Neisseria gonorrhoeae.
    Knapp JS; Falkow S; Holmes KK
    J Clin Pathol; 1975 Apr; 28(4):274-8. PubMed ID: 805162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Researches on the production of inhibitory substances by strains of "N. meningitidis" (author's transl)].
    Barbuti S; Montagna MT; Quarto M
    Ann Sclavo; 1979; 21(4):435-47. PubMed ID: 122053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriocin production by strains of Neisseria meningitidis.
    Kingsbury DT
    J Bacteriol; 1966 May; 91(5):1696-9. PubMed ID: 4957018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro inhibition of growth of Neisseria gonorrhoeae by Neisseria meningitidis isolated from the pharynx of homosexual men.
    Bisaillon JG; Turgeon P; Dubreuil D; Beaudet R; Sylvestre M; Ashton FE
    Sex Transm Dis; 1984; 11(4):296-300. PubMed ID: 6441274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriocin production by Neisseria gonorrhoeae.
    Lawton WD; Bellinger MA; Schling M; Gaafar HA
    Antimicrob Agents Chemother; 1976 Sep; 10(3):417-20. PubMed ID: 825028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Researches on some properties of inhibitory substances produced by strains of "N. meningitidis" (author's transl)].
    Barbuti S; Quarto M; Montagna MT
    Ann Sclavo; 1979; 21(4):448-55. PubMed ID: 45298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production, isolation and purification of bacteriocins expressed by two strains of Neisseria meningitidis.
    Allunans J; Bjørås M; Seeberg E; Bøvre K
    APMIS; 1998 Dec; 106(12):1181-7. PubMed ID: 10052727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriocins (meningocins) in Norwegian isolates of Neisseria meningitidis: possible role in the course of a meningococcal epidemic.
    Allunans J; Kristiansen KI; Assalkhou R; Bjørås M
    APMIS; 2008 May; 116(5):333-44. PubMed ID: 18452423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual antineisserial activity expressed by a systemic isolate of Neisseria meningitidis. antimeningococcal effect and properties.
    Allunans J; Bøvre K
    Scand J Infect Dis; 2001; 33(7):516-22. PubMed ID: 11515762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of endotoxin from Neisseria meningitidis. A short survey with a preliminary report on virulence in mice.
    Andersen BM; Solberg O
    NIPH Ann; 1980 Dec; 3(2):49-55. PubMed ID: 6784043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endotoxin release from neisseria meningitidis. Relationship between key bacterial characteristics and meningococcal disease.
    Andersen BM
    Scand J Infect Dis Suppl; 1989; 64():1-43. PubMed ID: 2515592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of bacteriocin-like substances by group D streptococci of human origin.
    Galvez A; Valdivia E; Maqueda M; Montoya E
    Microbios; 1985; 43(176S):223-32. PubMed ID: 3938512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of blood cells on the expression of bacteriocin-like activity in Neisseria meningitidis.
    Jyssum K; Allunans J
    Acta Pathol Microbiol Immunol Scand B; 1983 Aug; 91(4):245-50. PubMed ID: 6414242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of the meningococcal insertion sequence IS1301 in clonal lineages of Neisseria meningitidis.
    Hilse R; Stoevesandt J; Caugant DA; Claus H; Frosch M; Vogel U
    Epidemiol Infect; 2000 Apr; 124(2):337-40. PubMed ID: 10813160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.